Dr. Reddy's Announces Azacitidine for Injection Approved by FDA
September 17, 2013 at 05:59 AM EDT
Dr. Reddy's Laboratories (NYSE: RDY ) announced today that Azacitidine for Injection 100 mg/vial, a bioequivalent generic version of VIDAZA® (azacitidine for injection), is approved by the United States Food
